Samil Pharmaceutical Co.,Ltd (000520.KS)
KRW 13130.0
(-3.95%)
KRW 13130.0
(-3.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.19 Billion | 4.15 Billion | 1.41 Billion | 7.77 Billion | 10.59 Billion | -2.62 Billion |
| Net Income | 1.66 Billion | -28.28 Million | -5.34 Billion | 1.34 Billion | 786.25 Million | -8.56 Billion |
| Depreciation & Amortization | 5.36 Billion | 4.98 Billion | 4.71 Billion | 4.19 Billion | 4.01 Billion | 3.68 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -766.84 Million | -9.64 Billion | -5.18 Billion | -7.28 Billion | -1.46 Billion | -3.73 Billion |
| Other non-cash items | -2.06 Billion | 8.84 Billion | 7.24 Billion | 9.51 Billion | 7.25 Billion | 5.99 Billion |
| Investing Cash Flow | -19.8 Billion | -35.93 Billion | -45.3 Billion | -4.58 Billion | -26.05 Billion | -14.76 Billion |
| Investments in PPE | -24.39 Billion | -48.65 Billion | -33.09 Billion | -17.21 Billion | -14.48 Billion | -3.91 Billion |
| Acquisitions | 5.21 Billion | 272.79 Million | 822.96 Million | 169.43 Million | -188.03 Million | 5.56 Million |
| Investment purchases | -860 Million | -272.79 Million | -10.3 Billion | -26.34 Billion | -13.14 Billion | -9.06 Billion |
| Sales/Maturities of investments | 1.00 | 11.26 Billion | 508.1 Million | 38.15 Billion | 8.94 Billion | - |
| Other Investing Activities | 236.67 Million | 1.45 Billion | -3.24 Billion | 638.22 Million | -7.17 Billion | -1.78 Billion |
| Financing Cash Flow | 16.05 Billion | 29.7 Billion | 31.87 Billion | -3.32 Billion | 29.06 Billion | 19.45 Billion |
| Debt repayment | -16.82 Billion | -43.49 Billion | -3.78 Billion | -20.5 Billion | -22.19 Billion | -10.99 Billion |
| Dividends payments | - | -1 Billion | -938.64 Million | -918.89 Million | -610.35 Million | -765.53 Million |
| Common Stock Repurchased | -30.17 Million | - | -2.49 Billion | -1.99 Billion | 52.3 Billion | - |
| Common Stock Issuance | - | - | 39.08 Billion | - | 426.3 Thousand | 16.97 Billion |
| Other Financing Activities | 32.9 Billion | 74.2 Billion | 10.00 | 20.09 Billion | -439.29 Million | 14.23 Billion |
| Accounts receivables | -410.11 Million | -4.1 Billion | -1.15 Billion | -4.51 Billion | -2.5 Billion | 9.52 Billion |
| Accounts payables | 7.29 Billion | 5.13 Billion | -2.27 Billion | 1.67 Billion | -122.47 Million | 224.41 Million |
| Inventory | -7.91 Billion | -644.1 Million | -181.39 Million | -2.94 Billion | 551.41 Million | -8.64 Billion |
| Other working capital | 262.22 Million | -10.02 Billion | -1.57 Billion | -1.49 Billion | 615.26 Million | 4.91 Billion |
| Cash at beginning of period | 1.9 Billion | 3.99 Billion | 15.99 Billion | 16.71 Billion | 2.98 Billion | 991.23 Million |
| Cash at end of period | 906.14 Million | 1.9 Billion | 3.99 Billion | 15.99 Billion | 16.71 Billion | 2.98 Billion |
| Capital Expenditure | -24.39 Billion | -48.65 Billion | -33.09 Billion | -17.21 Billion | -14.48 Billion | -3.91 Billion |
| Effect of forex changes on cash | -1.44 Billion | -12.81 Million | 11.65 Million | -583.98 Million | 126.69 Million | -67.43 Million |
| Net cash flow / Change in cash | -997.32 Million | -2.08 Billion | -12 Billion | -721.24 Million | 13.72 Billion | 1.99 Billion |
| Free Cash Flow | -20.19 Billion | -44.5 Billion | -31.67 Billion | -9.43 Billion | -3.89 Billion | -6.53 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 350.31 Million | -1.74 Billion | 1.66 Billion | 894.11 Million | -657.04 Million | 719.05 Million |
| Depreciation & Amortization | 1.35 Billion | 1.35 Billion | 5.36 Billion | 1.35 Billion | 1.35 Billion | 1.34 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.02 Billion | -6.61 Billion | -766.84 Million | 16.95 Billion | -7.97 Billion | -7.8 Billion |
| Other non-cash items | 3.07 Billion | 10.89 Billion | -2.06 Billion | 37.79 Million | 170.52 Million | 796.4 Million |
| Investing Cash Flow | -23.54 Billion | 21.25 Billion | -19.8 Billion | -6.16 Billion | -15.86 Billion | -1.42 Billion |
| Investments in PPE | -1.07 Billion | -524.75 Million | -24.39 Billion | -17.67 Billion | -3.87 Billion | -1.52 Billion |
| Acquisitions | -22.54 Billion | 22.58 Billion | 5.21 Billion | 11.78 Billion | -11.37 Billion | - |
| Investment purchases | 394.32 Million | -394.32 Million | -860 Million | -860 Million | - | 40 Million |
| Sales/Maturities of investments | - | - | 1.00 | - | - | - |
| Other Investing Activities | -22.46 Billion | -407.57 Million | 236.67 Million | 575 Million | -612.84 Million | 63.99 Million |
| Financing Cash Flow | 21.67 Billion | -16.24 Billion | 16.05 Billion | -20.66 Billion | 30.59 Billion | 5.64 Billion |
| Debt repayment | -212.75 Million | -6.11 Billion | -16.82 Billion | -9.1 Billion | -2.12 Billion | -7.37 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 22.16 Billion | -22.16 Billion | -30.17 Million | -30.17 Million | - | 4.29 Million |
| Common Stock Issuance | -43.22 Million | - | - | -11.36 Billion | 11.38 Billion | -25.82 Million |
| Other Financing Activities | 21.89 Billion | -28.1 Million | 32.9 Billion | -48.57 Thousand | 21.32 Billion | 13.06 Billion |
| Accounts receivables | -965.2 Million | -650.68 Million | -410.11 Million | 2.86 Billion | -3.32 Billion | 82.71 Million |
| Accounts payables | 3.08 Billion | -7.53 Billion | 7.29 Billion | -2.65 Billion | -3.53 Billion | 15.75 Billion |
| Inventory | -3.22 Billion | 3.22 Billion | -7.91 Billion | -703.94 Million | 2.53 Billion | -11.19 Billion |
| Other working capital | 1.16 Billion | -1.65 Billion | 262.22 Million | 17.46 Billion | -3.65 Billion | -12.45 Billion |
| Cash at beginning of period | 1.71 Billion | 906.14 Million | 1.9 Billion | 9.6 Billion | 1.98 Billion | 3.04 Billion |
| Cash at end of period | 2 Billion | 1.71 Billion | 906.14 Million | 906.14 Million | 9.6 Billion | 1.98 Billion |
| Capital Expenditure | -1.07 Billion | -524.75 Million | -24.39 Billion | -17.67 Billion | -3.87 Billion | -1.52 Billion |
| Effect of forex changes on cash | 404.12 Million | -427.66 Million | -1.44 Billion | -1.1 Billion | -1.09 Million | -337.13 Million |
| Net cash flow / Change in cash | 292.88 Million | 810.57 Million | -997.32 Million | -8.69 Billion | 7.61 Billion | -1.06 Billion |
| Free Cash Flow | 679.13 Million | -4.29 Billion | -20.19 Billion | 1.57 Billion | -10.98 Billion | -6.47 Billion |
100090
LFST
AURUM
8104
VTNR
605069